Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Tegoprazan in GERD Patients With Nighttime Heartburn [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating tegoprazan for efficacy and safety in GERD patients with nighttime heartburn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Tegoprazan (tegoprazan)

Snippet

Sponsor: HK inno.N Corporation | Conditions: Gastroesophageal Reflux Disease | Phase 4 | Status: UNKNOWN